documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
39,003 rows where posted_year = 2023 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 25,422
- Other 10,416
- Notice 2,115
- Proposed Rule 537
- Rule 513
posted_year 1
- 2023 · 39,003 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA_FRDOC_0001-30344 | EPA | EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T13:38:49Z | 2023-28749 | 0 | 0 | 0900006486365be4 | ||
| EPA-HQ-OPP-2023-0597-0001 | EPA | EPA-HQ-OPP-2023-0597 | Exemption: Clothianidin | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-17T04:59:59Z | 2024-01-17T02:01:01Z | 2023-28772 | 0 | 0 | 0900006486365b43 | |
| EPA-R09-OAR-2023-0599-0002 | EPA | EPA-R09-OAR-2023-0599 | Maricopa County Rule 100 letter signed | Supporting & Related Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-30T01:55:16Z | 0 | 0 | 09000064863670ec | ||||
| EPA-R09-OAR-2023-0599-0003 | EPA | EPA-R09-OAR-2023-0599 | TSD MCAQD NSR Rule 100 2023-0599 12-4-2023 | Supporting & Related Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-30T01:55:29Z | 0 | 0 | 0900006486366f6a | ||||
| EPA-HQ-OLEM-2020-0107-0983 | EPA | Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals from Electric Utilities; Legacy Surface Impoundments EPA-HQ-OLEM-2020-0107 | Memo to docket Meeting with Duke Energy November 29, 2023 with attached presentation | Supporting & Related Material | Meeting Materials | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-30T01:32:20Z | 0 | 0 | 09000064863670eb | |||
| EPA-HQ-OPP-2023-0597-0002 | EPA | EPA-HQ-OPP-2023-0597 | FIFRA Section 18 Emergency Exemption Renewal Request For Belay Insecticide (clothianidin; 23.0%) (24FL01- Application - 20231117) | Supporting & Related Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-30T01:38:22Z | 0 | 0 | 090000648634947f | ||||
| EPA-R06-OAR-2022-0907-0006 | EPA | EPA-R06-OAR-2022-0907 | AR039.06 Air Quality State Implementation Plans; Approvals and Promulgations; Arkansas; Revisions to Rule 19: Rules of the Arkansas Plan of Implementation for Air Pollution Control, Final rule, 5 pages. | Rule | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T15:30:24Z | 2023-28497 | 0 | 0 | 0900006486365b3b | ||
| EPA-R09-OAR-2023-0449-0001 | EPA | EPA-R09-OAR-2023-0449 | Air Quality State Implementation Plans; Approvals and Promulgations: California; San Luis Obispo County Air Pollution Control District; New Source Review | Proposed Rule | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-29T20:05:11Z | 2023-28750 | 0 | 0 | 0900006486365bdf | |
| EPA-R09-OAR-2023-0599-0004 | EPA | EPA-R09-OAR-2023-0599 | Rule100-SIP Revision | Supporting & Related Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-30T01:55:41Z | 0 | 0 | 0900006486366f6b | ||||
| EPA-HQ-ORD-2012-0830-0100 | EPA | EPA-HQ-ORD-2012-0830 | Availability of the Benchmark Dose (BMD) Model Code and BMD Modeling Output Files for the Draft Integrated Risk Information System (IRIS) Toxicological Review of Inorganic Arsenic | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-17T04:59:59Z | 2024-01-18T02:00:45Z | 2023-28766 | 0 | 0 | 0900006486365bde | |
| FDA-2022-E-2011-0005 | FDA | FDA-2022-E-2011 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:12:16Z | 0 | 0 | 0900006486365699 | ||
| FDA-2022-E-2010-0005 | FDA | FDA-2022-E-2010 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:12:02Z | 0 | 0 | 0900006486365697 | ||
| FDA-2022-E-2014-0005 | FDA | FDA-2022-E-2014 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:09:57Z | 0 | 0 | 0900006486365a1a | ||
| FDA-2022-N-2226-0144 | FDA | FDA-2022-N-2226 | Tab C - FDA Salt Substitutes - NPRM and PRIA - Final to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T17:42:15Z | 0 | 0 | 0900006486366ef1 | |||
| FDA-2019-N-4750-0041 | FDA | FDA-2019-N-4750 | Memorandum to FDA DMS on Partially Hydrogenated Oils | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:12Z | 0 | 0 | 0900006486365e65 | |||
| FDA-2019-N-4750-0045 | FDA | FDA-2019-N-4750 | Tab A - PHOs RIA - Original to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:30Z | 0 | 0 | 0900006486365e69 | |||
| FDA-1997-S-0006-2049 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to Vedistry Pvt Ltd. | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:04:52Z | 0 | 0 | 090000648635f527 | ||
| FDA-1997-S-0006-2046 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:04:18Z | 0 | 0 | 090000648635f0c5 | ||
| FDA-1997-S-0006-2043 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from CFSAN to Arbonne International LLC | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:03:49Z | 0 | 0 | 090000648635de73 | ||
| FDA-1997-S-0006-2048 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:04:42Z | 0 | 0 | 090000648635f525 | ||
| FDA-2023-H-5636-0001 | FDA | FDA-2023-H-5636 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:34:31Z | 0 | 0 | 0900006486361437 | ||
| FDA-2022-E-2012-0005 | FDA | FDA-2022-E-2012 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:12:29Z | 0 | 0 | 090000648636569b | ||
| FDA-2019-E-3218-0005 | FDA | FDA-2019-E-3218 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:03:25Z | 0 | 0 | 0900006486365a16 | ||
| FDA-2022-E-2013-0005 | FDA | FDA-2022-E-2013 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:12:42Z | 0 | 0 | 0900006486365ce2 | ||
| FDA-2019-N-4750-0048 | FDA | FDA-2019-N-4750 | Tab B - PHOs PRIA - Comparison OMB Original to Final | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:55Z | 0 | 0 | 0900006486365e8c | |||
| FDA-2019-N-4750-0051 | FDA | FDA-2019-N-4750 | Tab C - PHOs NPRM - Final to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:57:23Z | 0 | 0 | 0900006486365e91 | |||
| FDA-2023-H-5667-0001 | FDA | FDA-2023-H-5667 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:57:02Z | 0 | 0 | 0900006486365657 | ||
| FDA-1997-S-0006-2044 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to CalmCo LLC | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:03:58Z | 0 | 0 | 090000648635d608 | ||
| FDA-2023-H-5657-0001 | FDA | FDA-2023-H-5657 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2024-01-01T05:00:00Z | 2024-01-01T19:24:51Z | 0 | 0 | 0900006486366f65 | ||
| FDA-2023-H-5410-0001 | FDA | FDA-2023-H-5410 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2024-01-01T05:00:00Z | 2024-01-01T18:58:41Z | 0 | 0 | 0900006486365c81 | ||
| FDA-2019-N-4750-0046 | FDA | FDA-2019-N-4750 | Tab B - PHOs DFR - Comparison OMB Original to Final | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:46Z | 0 | 0 | 0900006486365e6a | |||
| FDA-2019-N-4750-0047 | FDA | FDA-2019-N-4750 | Tab B - PHOs NPRM - Comparison OMB Original to Final | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:50Z | 0 | 0 | 0900006486365e6b | |||
| FDA-2019-N-4750-0050 | FDA | FDA-2019-N-4750 | Tab C - PHOs DFR - Final to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:57:18Z | 0 | 0 | 0900006486365e8e | |||
| FDA-2023-H-5663-0001 | FDA | FDA-2023-H-5663 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:52:49Z | 0 | 0 | 090000648636564e | ||
| FDA-2023-H-5661-0001 | FDA | FDA-2023-H-5661 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:39:48Z | 0 | 0 | 0900006486366919 | ||
| FDA-2023-H-5662-0001 | FDA | FDA-2023-H-5662 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:41:58Z | 0 | 0 | 090000648636692b | ||
| FDA-2022-N-2226-0142 | FDA | FDA-2022-N-2226 | Tab A - FDA Salt Substitutes NPRM and PRIA - Original to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T17:41:54Z | 0 | 0 | 0900006486366edd | |||
| FDA-2022-N-2226-0141 | FDA | FDA-2022-N-2226 | Memorandum to FDA DMS on Salt Substitutes NPRM | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T17:41:49Z | 0 | 0 | 0900006486366eda | |||
| FDA-2023-U-5565-0001 | FDA | FDA-2023-U-5565 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T17:07:31Z | 0 | 0 | 09000064863612e4 | ||
| FDA-2023-H-5665-0001 | FDA | FDA-2023-H-5665 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T17:15:06Z | 0 | 0 | 0900006486365654 | ||
| FDA-2023-H-5269-0001 | FDA | FDA-2023-H-5269 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T17:24:00Z | 0 | 0 | 0900006486365665 | ||
| FDA-1997-S-0006-2050 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to CalmCo LLC | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:05:03Z | 0 | 0 | 090000648635f529 | ||
| FDA-2019-E-5256-0005 | FDA | FDA-2019-E-5256 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T13:26:57Z | 0 | 0 | 090000648636562d | ||
| FDA-2019-N-4750-0044 | FDA | FDA-2019-N-4750 | Tab A - PHOs PRIA - Original to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:25Z | 0 | 0 | 0900006486365e68 | |||
| FDA-2019-N-4750-0049 | FDA | FDA-2019-N-4750 | Tab B - PHOs RIA - Comparison OMB Original to Final | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:57:01Z | 0 | 0 | 0900006486365e8d | |||
| FDA-2019-N-4750-0053 | FDA | FDA-2019-N-4750 | Tab C - PHOs RIA - Final to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:57:32Z | 0 | 0 | 0900006486365e93 | |||
| FDA-2023-H-5666-0001 | FDA | FDA-2023-H-5666 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:46:57Z | 0 | 0 | 0900006486364c23 | ||
| FDA-2023-H-5660-0001 | FDA | FDA-2023-H-5660 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:38:09Z | 0 | 0 | 09000064863665e4 | ||
| FDA-2023-H-5672-0001 | FDA | FDA-2023-H-5672 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T17:28:45Z | 0 | 0 | 0900006486365662 | ||
| FDA-2019-E-3017-0005 | FDA | FDA-2019-E-3017 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:13:37Z | 0 | 0 | 09000064863656c8 | ||
| FDA-2022-E-2016-0005 | FDA | FDA-2022-E-2016 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:10:40Z | 0 | 0 | 0900006486365692 | ||
| FDA-2019-E-3287-0005 | FDA | FDA-2019-E-3287 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:14:00Z | 0 | 0 | 0900006486365c60 | ||
| FDA-2023-H-5673-0001 | FDA | FDA-2023-H-5673 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T15:05:01Z | 0 | 0 | 090000648636568b | ||
| FDA-2023-H-5674-0001 | FDA | FDA-2023-H-5674 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T15:08:02Z | 0 | 0 | 0900006486365c7b | ||
| FDA-2023-H-5603-0001 | FDA | FDA-2023-H-5603 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:34:53Z | 0 | 0 | 0900006486365669 | ||
| FDA-2019-N-4750-0052 | FDA | FDA-2019-N-4750 | Tab C - PHOs PRIA - Final to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:57:27Z | 0 | 0 | 0900006486365e92 | |||
| FDA-2023-H-5177-0001 | FDA | FDA-2023-H-5177 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-01T05:00:00Z | 2023-12-01T15:00:37Z | 0 | 0 | 09000064862c07f3 | ||
| FDA-2023-H-5658-0001 | FDA | FDA-2023-H-5658 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2024-01-02T05:00:00Z | 2024-01-02T13:25:31Z | 0 | 0 | 0900006486366f68 | ||
| FDA-2022-N-2226-0143 | FDA | FDA-2022-N-2226 | Tab B - FDA Salt Substitutes NPRM and PRIA - Comparison OMB Original to Final | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T17:42:10Z | 0 | 0 | 0900006486366ee2 | |||
| FDA-1997-S-0006-2045 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to Robinson Pharma | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:04:07Z | 0 | 0 | 090000648635f0c2 | ||
| FDA-1997-S-0006-2047 | FDA | Dietary Supplements, Courtesy Letters (Letters of Objection) FDA-1997-S-0006 | Courtesy letter and related material from FDA CFSAN to Wooshin Industrial Co., Ltd. | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T18:04:30Z | 0 | 0 | 090000648635f521 | ||
| FDA-2023-H-5664-0001 | FDA | FDA-2023-H-5664 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T17:02:17Z | 0 | 0 | 0900006486365651 | ||
| FDA-2023-H-5670-0001 | FDA | FDA-2023-H-5670 | Complaint | Other | Complaint | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T16:51:21Z | 0 | 0 | 0900006486366931 | ||
| FDA-2019-N-4750-0042 | FDA | FDA-2019-N-4750 | Tab A - PHOs DFR - Original to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:16Z | 0 | 0 | 0900006486365e66 | |||
| FDA-2022-E-2009-0005 | FDA | FDA-2022-E-2009 | Letter to U. S. Patent and Trademark Office from FDA CDER | Other | Letter(s) | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2023-12-29T14:11:49Z | 0 | 0 | 0900006486365c63 | ||
| FDA-2019-N-4750-0043 | FDA | FDA-2019-N-4750 | Tab A - PHOs NPRM - Original to OMB | Supporting & Related Material | Background Material | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T16:56:21Z | 0 | 0 | 0900006486365e67 | |||
| FWS-R8-ES-2023-0191-0001 | FWS | Receipt of Proposed Habitat Conservation Plan for Seven Species; Sacramento Municipal Utility District, Sacramento County, CA; Draft Environmental Assessment FWS-R8-ES-2023-0191 | Draft Habitat Conservation Plan and Draft Environmental Assessment; Sacramento Municipal Utility District Operations, Maintenance, and New Construction Habitat Conservation Plan, Sacramento County, CA | Notice | 2023-12-29T05:00:00Z | 2023 | 12 | 2023-12-29T05:00:00Z | 2024-01-30T04:59:59Z | 2024-01-30T02:00:37Z | 2023-28719 | 0 | 0 | 0900006486365625 | |
| EPA-R09-OAR-2023-0203-0009 | EPA | EPA-R09-OAR-2023-0203 | Air Quality State Implementation Plans; Approvals and Promulgations: California State Implementation Plan; San Francisco Bay Area | Rule | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T15:46:20Z | 2023-28494 | 0 | 0 | 09000064863617e1 | ||
| EPA-R09-OAR-2023-0203-0010 | EPA | EPA-R09-OAR-2023-0203 | Final Docket Index for the Approval and Promulgation of Implementation Plans; Revisions to the CA SIP; SF Bay Area | Supporting & Related Material | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T02:07:36Z | 0 | 0 | 0900006486361443 | ||||
| EPA-HQ-OPPT-2015-0436-0044 | EPA | EPA-HQ-OPPT-2015-0436 | FAQs | Supporting & Related Material | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:38:35Z | 0 | 0 | 0900006484f7a78f | ||||
| EPA-R09-OAR-2023-0203-0011 | EPA | EPA-R09-OAR-2023-0203 | E. 88 FR 89587 Approval And Promulgation of Implementation Plans; Revisions to the CA State Plan; SF Bay Area | Supporting & Related Material | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T02:07:48Z | 0 | 0 | 0900006486361445 | ||||
| EPA-R10-OAR-2019-0647-0007 | EPA | EPA-R10-OAR-2019-0647 | Air Quality State Implementation Plans; Approvals and Promulgations: Washington; Excess Emissions, Startup, Shutdown, and Malfunction Revisions | Rule | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T16:35:51Z | 2023-28294 | 0 | 0 | 09000064863618c5 | ||
| EPA-R02-OAR-2023-0175-0006 | EPA | EPA-R02-OAR-2023-0175 | Air Quality State Implementation Plans; Approvals and Promulgations: New York; Emission Statement Program | Rule | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-29T19:16:51Z | 2023-28343 | 0 | 0 | 0900006486361798 | ||
| EPA-HQ-OA-2013-0320-0031 | EPA | Technical Guidance for Assessing Environmental Justice in Regulatory Analysis EPA-HQ-OA-2013-0320 | Guidance: Assessing Environmental Justice in Regulatory Analysis | Notice | Extension of Comment Period | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T15:37:42Z | 2023-28598 | 0 | 0 | 0900006486361790 | ||
| EPA-HQ-OW-2015-0680-0423 | EPA | EPA-HQ-OW-2015-0680 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Use of Lead Free Pipes, Fittings, Fixtures, Solder and Flux for Drinking Water (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:01:47Z | 2023-28640 | 0 | 0 | 0900006486361660 | |
| EPA-HQ-OPPT-2015-0436-0043 | EPA | EPA-HQ-OPPT-2015-0436 | Supporting Statement for OMB Review | Supporting & Related Material | ICR Supporting Statement | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:38:47Z | 0 | 0 | 0900006484f7a78e | |||
| EPA-HQ-OPPT-2023-0309-0021 | EPA | EPA-HQ-OPPT-2023-0309 | The Asbestos Medicine Seminar November 15-17, 2023, Retrospective: The DRI Presentation of 2023, The North Carolina Asbestos Plants, Revisited: 2023 | Supporting & Related Material | Publication - Copyrighted Materials | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:39:26Z | 0 | 0 | 0900006486361325 | |||
| EPA-HQ-OLEM-2023-0244-0002 | EPA | Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals (CCR) EPA-HQ-OLEM-2023-0244 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Disposal of Coal Combustion Residuals From Electric Utilities (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:15:36Z | 2023-28639 | 0 | 0 | 090000648636172c | |
| EPA-R06-OAR-2023-0090-0014 | EPA | EPA-R06-OAR-2023-0090 | OK043.13 Air Quality State Implementation Plans; Approvals and Promulgations: Oklahoma; Revisions to Air Pollution Control Rules, Final rule, first 4 pages | Rule | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T15:28:21Z | 2023-28496 | 0 | 0 | 09000064863618c7 | ||
| EPA-HQ-OPPT-2015-0436-0047 | EPA | EPA-HQ-OPPT-2015-0436 | CDX User Guide | Supporting & Related Material | Publication - USEPA | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:39:00Z | 0 | 0 | 0900006484f7a792 | |||
| EPA-HQ-OPPT-2023-0309-0020 | EPA | EPA-HQ-OPPT-2023-0309 | Letter Peer Reviewer Comments on the White Paper: Quantitative Human Health Approach to be Applied in the Risk Evaluation for Asbestos Part 2—Supplemental Evaluation including Legacy Uses and Associated Disposals of Asbestos | Supporting & Related Material | Memorandum | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:39:13Z | 0 | 0 | 0900006486361307 | |||
| EPA-HQ-OPPT-2015-0436-0045 | EPA | EPA-HQ-OPPT-2015-0436 | Consultation - TSCA Section 4 Test Orders Website Update | Supporting & Related Material | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:38:22Z | 0 | 0 | 0900006484f7a790 | ||||
| EPA-HQ-OW-2017-0300-1915 | EPA | EPA-HQ-OW-2017-0300 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Lead and Copper Rule Revisions | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:24:27Z | 2023-28641 | 0 | 0 | 0900006486361915 | |
| EPA-HQ-OPPT-2015-0436-0042 | EPA | EPA-HQ-OPPT-2015-0436 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions From Testing Requirements (Renewal) | Notice | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-01-30T04:59:59Z | 2023-12-28T15:09:11Z | 2023-28663 | 0 | 0 | 09000064863616e9 | |
| EPA-HQ-OPPT-2015-0436-0046 | EPA | EPA-HQ-OPPT-2015-0436 | Emergency Request Memorandum to OMB | Supporting & Related Material | Memorandum | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-29T01:38:09Z | 0 | 0 | 0900006484f7a791 | |||
| FDA-2023-H-5639-0001 | FDA | FDA-2023-H-5639 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T15:19:51Z | 0 | 0 | 090000648635d710 | ||
| FDA-2023-H-5650-0001 | FDA | FDA-2023-H-5650 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T17:50:58Z | 0 | 0 | 0900006486361319 | ||
| FDA-2023-D-5408-0002 | FDA | FDA-2023-D-5408 | Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry - Final Guidance | Other | Guidance | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-11-12T06:24:20Z | 1 | 0 | 090000648635c332 | ||
| FDA-2021-N-0039-0002 | FDA | FDA-2021-N-0039 | Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-11-12T06:21:06Z | 2023-28594 | 1 | 0 | 090000648636182b | |
| FDA-2023-H-5647-0001 | FDA | FDA-2023-H-5647 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T18:23:02Z | 0 | 0 | 0900006486361407 | ||
| FDA-2023-H-5648-0001 | FDA | FDA-2023-H-5648 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T18:26:47Z | 0 | 0 | 090000648636140a | ||
| FDA-2023-H-5643-0001 | FDA | FDA-2023-H-5643 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T17:54:09Z | 0 | 0 | 09000064863612e1 | ||
| FDA-2023-H-5645-0001 | FDA | FDA-2023-H-5645 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T21:03:53Z | 0 | 0 | 0900006486364790 | ||
| FDA-2023-D-4177-0021 | FDA | FDA-2023-D-4177 | Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T15:10:09Z | 2023-28595 | 0 | 0 | 090000648636165b | |
| FDA-2023-D-4299-0002 | FDA | FDA-2023-D-4299 | Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry | Other | Guidance | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-03-28T03:59:59Z | 2024-11-12T06:25:10Z | 1 | 0 | 0900006486364261 | |
| FDA-2023-H-5637-0001 | FDA | FDA-2023-H-5637 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2024-01-01T05:00:00Z | 2024-01-01T19:25:25Z | 0 | 0 | 09000064863647c6 | ||
| FDA-2020-Q-1295-0026 | FDA | FDA-2020-Q-1295 | Withdrawal request for docket number FDA-2020-Q-1295 | Other | Withdrawal | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T18:40:58Z | 0 | 0 | 0900006486364403 | ||
| FDA-2020-Q-1295-0027 | FDA | FDA-2020-Q-1295 | FDA response to a withdrawal request for CA and Migraine Final | Other | Acknowledgement Letter/Receipt | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T18:41:04Z | 0 | 0 | 0900006486364405 | ||
| FDA-2023-D-4177-0022 | FDA | FDA-2023-D-4177 | Quality Considerations for Topical Ophthalmic Drug Products; Guidance for Industry; Draft Guidance | Other | Guidance | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2024-02-27T04:59:59Z | 2025-02-04T02:01:06Z | 1 | 0 | 09000064863613f7 | |
| FDA-2023-H-5644-0001 | FDA | FDA-2023-H-5644 | Complaint | Other | Complaint | 2023-12-28T05:00:00Z | 2023 | 12 | 2023-12-28T05:00:00Z | 2023-12-28T18:27:41Z | 0 | 0 | 09000064863612e7 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);